Ai Inoue

567 total citations
18 papers, 385 citations indexed

About

Ai Inoue is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Ai Inoue has authored 18 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Ai Inoue's work include Cardiovascular Health and Disease Prevention (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Cancer-related gene regulation (3 papers). Ai Inoue is often cited by papers focused on Cardiovascular Health and Disease Prevention (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Cancer-related gene regulation (3 papers). Ai Inoue collaborates with scholars based in Japan, United States and Italy. Ai Inoue's co-authors include Nobuyuki Ohtsuka, Hitomi Tomita, Atsushi Kamitani, Ryuichi Kawamoto, Rie Fujita, Fumiki Katsuoka, M. Takayama, Masayuki Yamamoto, Hozumi Motohashi and Emery H. Bresnick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Ai Inoue

17 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ai Inoue Japan 12 141 71 62 57 48 18 385
Faize Yüksel Türkiye 14 80 0.6× 71 1.0× 103 1.7× 90 1.6× 42 0.9× 31 434
Takashi Iwakiri Japan 14 89 0.6× 81 1.1× 53 0.9× 74 1.3× 42 0.9× 20 408
Pavel Kraml Czechia 12 65 0.5× 44 0.6× 109 1.8× 63 1.1× 53 1.1× 45 387
Giuseppina Cerullo Italy 11 130 0.9× 90 1.3× 84 1.4× 44 0.8× 17 0.4× 14 528
Courtney E. Leik United States 8 93 0.7× 41 0.6× 82 1.3× 57 1.0× 76 1.6× 9 430
Andrew T. Treweeke United Kingdom 10 146 1.0× 40 0.6× 36 0.6× 24 0.4× 26 0.5× 18 414
Eleftheria Vardaki Greece 11 148 1.0× 33 0.5× 31 0.5× 60 1.1× 29 0.6× 19 455
R Rapisarda Italy 9 81 0.6× 35 0.5× 55 0.9× 28 0.5× 24 0.5× 26 287
Franck Péan France 10 130 0.9× 75 1.1× 85 1.4× 103 1.8× 144 3.0× 10 518
Magnus Ulvsbäck Sweden 7 144 1.0× 45 0.6× 47 0.8× 36 0.6× 20 0.4× 7 664

Countries citing papers authored by Ai Inoue

Since Specialization
Citations

This map shows the geographic impact of Ai Inoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ai Inoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ai Inoue more than expected).

Fields of papers citing papers by Ai Inoue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ai Inoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ai Inoue. The network helps show where Ai Inoue may publish in the future.

Co-authorship network of co-authors of Ai Inoue

This figure shows the co-authorship network connecting the top 25 collaborators of Ai Inoue. A scholar is included among the top collaborators of Ai Inoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ai Inoue. Ai Inoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Izutsu, Koji, Kenji Ishitsuka, Dai Maruyama, et al.. (2023). Valemetostat for Relapsed or Refractory B-Cell Lymphomas: Primary Results from a Phase 1 Trial. Blood. 142(Supplement 1). 1731–1731. 3 indexed citations
4.
Inoue, Ai, Haruka Shinohara, Ken‐ichi Miyamoto, et al.. (2018). Chronic myeloid leukemia stem cells and molecular target therapies for overcoming resistance and disease persistence. International Journal of Hematology. 108(4). 365–370. 17 indexed citations
5.
Fujiwara, Tohru, Ai Inoue, Masahiro Kobayashi, et al.. (2014). 3-Deazaneplanocin A (DZNep), an Inhibitor of S-Adenosylmethionine-dependent Methyltransferase, Promotes Erythroid Differentiation. Journal of Biological Chemistry. 289(12). 8121–8134. 43 indexed citations
6.
Inoue, Ai, Tohru Fujiwara, Yoko Okitsu, et al.. (2013). Elucidation of the role of LMO2 in human erythroid cells. Experimental Hematology. 41(12). 1062–1076.e1. 11 indexed citations
7.
Ichikawa, Satoshi, Noriko Fukuhara, Ai Inoue, et al.. (2013). Clinicopathological analysis of primary adrenal diffuse large B-cell lymphoma: effectiveness of rituximab-containing chemotherapy including central nervous system prophylaxis. Experimental Hematology and Oncology. 2(1). 19–19. 21 indexed citations
8.
Kurokawa, Daisuke, Tomomi Ohmura, Hajime Ogino, et al.. (2010). Evolutionary origin of the Otx2 enhancer for its expression in visceral endoderm. Developmental Biology. 342(1). 110–120. 6 indexed citations
9.
Motohashi, Hozumi, Rie Fujita, M. Takayama, et al.. (2010). Molecular Determinants for Small Maf Protein Control of Platelet Production. Molecular and Cellular Biology. 31(1). 151–162. 12 indexed citations
10.
Motohashi, Hozumi, Momoko Kimura, Rie Fujita, et al.. (2009). NF-E2 domination over Nrf2 promotes ROS accumulation and megakaryocytic maturation. Blood. 115(3). 677–686. 86 indexed citations
11.
Kawamoto, Ryuichi, et al.. (2007). Preperitoneal fat thickness by ultrasonography and obesity-related disorders. Journal of Medical Ultrasonics. 34(2). 93–99. 15 indexed citations
12.
Inoue, Ai, Kojiro Michitaka, Ichiro Konishi, et al.. (2007). Budd-Chiari Syndrome Associated with Hypereosinophilic Syndrome; A Case Report. Internal Medicine. 46(14). 1095–1100. 16 indexed citations
13.
Kawamoto, Ryuichi, Hitomi Tomita, Ai Inoue, Nobuyuki Ohtsuka, & Atsushi Kamitani. (2007). Metabolic Syndrome may be a Risk Factor for Early Carotid Atherosclerosis in Women but not in Men. Journal of Atherosclerosis and Thrombosis. 14(1). 36–43. 44 indexed citations
14.
Kawamoto, Ryuichi, et al.. (2007). Aging and metabolic syndrome effect on carotid atherosclerosis assessed by ultrasonography. Geriatrics and gerontology international. 7(3). 221–228. 6 indexed citations
15.
Kawamoto, Ryuichi, Hitomi Tomita, Nobuyuki Ohtsuka, Ai Inoue, & Atsushi Kamitani. (2007). Metabolic Syndrome, Diabetes and Subclinical Atherosclerosis as Assessed by Carotid Intima-Media Thickness. Journal of Atherosclerosis and Thrombosis. 14(2). 78–85. 38 indexed citations
16.
Kurokawa, Daisuke, Ai Inoue, Rika Nakayama, et al.. (2006). Evolutionary constraint on Otx2 neuroectoderm enhancers-deep conservation from skate to mouse and unique divergence in teleost. Proceedings of the National Academy of Sciences. 103(51). 19350–19355. 29 indexed citations
17.
Kawamoto, Ryuichi, Hitomi Tomita, Ai Inoue, Nobuyuki Ohtsuka, & Atsushi Kamitani. (2006). Impact of C-reactive Protein on the Likelihood of Carotid Atherosclerosis in Japanese Adults. Journal of Atherosclerosis and Thrombosis. 13(4). 175–182. 9 indexed citations
18.
Murakami, Masato, et al.. (2005). Argon plasma coagulation for the treatment of early gastric cancer.. PubMed. 51(60). 1658–61. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026